[1] |
Chan JF, Lau SK, Yuen KY, et al. Talaromyces (Penicillium) marneffei infection in non-HIV-infected patients[J]. Emerg Microbes Infect, 2016, 5(3): e19.
|
[2] |
Hu Y, Zhang J, Li X, et al. Penicillium marneffei infection: an emerging disease in mainland China[J]. Mycopathologia, 2013, 175(1-2): 57-67.
doi: 10.1007/s11046-012-9577-0
|
[3] |
Zeng Q, Jin Y, Yin G, et al. Peripheral immune profile of children with Talaromyces marneffei infections: a retrospective analysis of 21 cases[J]. BMC Infect Dis, 2021, 21(1): 287.
doi: 10.1186/s12879-021-05978-z
|
[4] |
Cao C, Xi L, Chaturvedi V. Talaromycosis (Penicilliosis) due to Talaromyces (Penicillium) marneffei: insights into the clinical trends of a major fungal disease 60 years after the discovery of the pathogen[J]. Mycopathologia, 2019, 184(6): 709-720.
doi: 10.1007/s11046-019-00410-2
|
[5] |
Hu F, Liu S, Liu Y, et al. The decreased number and function of lymphocytes is associated with Penicillium marneffei infection in HIV-negative patients[J]. J Microbiol Immunol Infect, 2021, 54(3): 457-465.
doi: 10.1016/j.jmii.2020.02.007
|
[6] |
Pruksaphon K, Intaramat A, Ratanabanangkoon K, et al. Development and characterization of an immunochromatographic test for the rapid diagnosis of Talaromyces (Penicillium) marneffei[J]. PLoS One, 2018, 13(4): e0195596.
doi: 10.1371/journal.pone.0195596
|
[7] |
Fan H, Huang L, Jin Y, et al. Study of Penicillium marneffei infection in pediatric patients without human immunodeficiency virus infection in China[J]. Pediatr Allergy Immunol Pulmonol, 2017, 30(1): 53-59.
doi: 10.1089/ped.2016.0722
|
[8] |
Guo J, Li BK, Li TM, et al. Characteristics and prognosis of Talaromyces marneffei infection in non-HIV-infected children in Southern China[J]. Mycopathologia, 2019, 184(6): 735-745.
doi: 10.1007/s11046-019-00373-4
|
[9] |
Vece TJ, Watkin LB, Nicholas S, et al. Copa syndrome: a novel autosomal dominant immune dysregulatory disease[J]. J Clin Immunol, 2016, 36(4): 377-387.
doi: 10.1007/s10875-016-0271-8
|
[10] |
Lau SK, Lo GC, Lam CS, et al. In vitro activity of posaconazole against Talaromyces marneffei by broth microdilution and Etest methods and comparison to itraconazole, voriconazole, and anidulafungin[J]. Antimicrob Agents Chemother, 2017, 61(3): e01480-16.
|
[11] |
Lee PP, Chan KW, Lee TL, et al. Penicilliosis in children without HIV infection--are they immunodeficient?[J]. Clin Infect Dis, 2012, 54(2): e8-e19.
|